Technische Universitaet Dresden

At Technische Universitaet Dresden, clinical research in nervous system diseases spans major conditions such as amyotrophic lateral sclerosis, Parkinson’s disease, multiple sclerosis, migraine, and Huntington’s disease. These studies are focused on testing new therapies, improving symptom control, and better understanding disease progression.

• Therapeutic focus on neurology, mental disorders, and physiological processes
• Research in ALS, Parkinson’s disease, multiple sclerosis, and migraine
• Trials aiming to evaluate treatment effectiveness and support earlier, more precise care

Work at the Klinik und Poliklinik für Neurologie also includes studies of rare neurological syndromes and immune-related nervous system conditions, reflecting a broad effort to advance both diagnosis and treatment options.

This site has a major research presence in hematologic diseases, especially acute myeloid leukemia, myelodysplastic syndromes, chronic lymphocytic leukemia, multiple myeloma, and lymphomas. Many studies explore new treatment combinations, disease control after transplant, and strategies for patients with relapsed or high-risk blood cancers.

• Strong activity in leukemia, lymphoma, and plasma cell disorders
• Trials in allogeneic transplantation and post-transplant maintenance
• Research designed to improve response rates, remission depth, and long-term outcomes

Across these studies, investigators at Technische Universitaet Dresden are helping refine treatment pathways for both newly diagnosed and difficult-to-treat blood cancers.

Clinical trials in oncology at this site frequently address breast cancer, ovarian cancer, endometrial cancer, cervical cancer, bladder cancer, and prostate cancer. The research often focuses on biomarker-guided treatment, recurrence prevention, and better options for advanced or metastatic disease.

• Key work in breast neoplasms and female urogenital diseases
• Studies of urothelial, prostate, and endometrial cancers
• Trials aimed at improving survival, reducing recurrence, and personalizing therapy

Several projects also examine targeted and immune-based approaches, showing a strong interest in more precise cancer care.

Another major area of research covers lung cancer, gastric cancer, colorectal cancer, pancreatic cancer, esophageal cancer, and biliary tract cancer. These trials are designed to test new treatments, improve disease control, and support patients with advanced solid tumors.

• Broad activity in respiratory tract diseases and digestive system diseases
• Research in non-small cell lung cancer, small cell lung cancer, and gastrointestinal neoplasms
• Studies evaluating targeted therapy, immunotherapy, and combination treatment approaches

The oncology portfolio at Technische Universitaet Dresden includes both common cancers and harder-to-treat molecular subtypes, reflecting a broad precision-medicine approach.

Trials in immune system diseases and skin and connective tissue diseases include atopic dermatitis, psoriasis, hidradenitis suppurativa, urticaria, systemic lupus erythematosus, and rheumatoid arthritis. The main goal is to improve symptom relief, disease control, and quality of life for people living with chronic inflammatory conditions.

• Research spanning dermatology, rheumatology, and autoimmune disease
• Studies in eczema, psoriatic disease, lupus, and urticaria
• Trials focused on safer, more effective long-term treatment options

These studies highlight a strong interest in chronic immune-mediated disorders and their day-to-day impact on patients.

Clinical research also extends to cardiovascular diseases, metabolic disorders, and pulmonary hypertension. Conditions such as atrial fibrillation, atherosclerotic cardiovascular disease, heart failure, diabetes, hyperlipidemia, and pulmonary arterial hypertension are studied to improve prevention, risk reduction, and treatment effectiveness.

• Focus on cardiology, metabolism, and respiratory medicine
• Trials in stroke prevention, lipid disorders, and blood sugar control
• Research aimed at lowering complications and improving long-term disease management

At this educational institution in Dresden, these studies support more individualized care for patients with overlapping heart, lung, and metabolic conditions.

A smaller but important part of the portfolio includes rare diseases, immune-mediated disorders, and studies using diagnostic and therapeutic techniques to better define disease behavior. Research topics include immunodeficiency, vasculitis, myasthenia gravis, nephropathy, and selected genetic or metabolic conditions.

• Work in immune system processes, pathological conditions, and diagnostic research
• Trials addressing rare, complex, and biomarker-defined diseases
• Studies intended to improve diagnosis, monitoring, and targeted treatment selection

This area adds depth to the research profile of Technische Universitaet Dresden, combining specialty care with efforts to advance modern precision medicine.